Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 649, pseudogene (RN7SL649P)

Target
RN7SL649P
Molecular classification
Other, Pseudogene, Non-coding RNA, 7SL RNA-type pseudogene
01

Overview

RNA, 7SL, cytoplasmic 649, pseudogene (RN7SL649P) is a human pseudogene identified as a processed non-coding RNA similar in sequence to the functional 7SL RNA, a core component of the signal recognition particle (SRP) complex essential for protein targeting to the endoplasmic reticulum[1][3][5]. Unlike its functional parent RNA, RN7SL649P has lost the ability to produce functional product due to alterations and typically lacks promoter or regulatory sequences for active gene expression[1][2]. Pseudogenes like RN7SL649P do not encode proteins and are not considered receptors, enzymes, or other conventional drug targets[1][2][4][5]. However, in some biological contexts, other pseudogenes have been shown to act as miRNA sponges or regulate parental gene expression, but specific functional or disease associations for RN7SL649P itself have not been described[2][4][5]. ### Notes on interpretation - This entry refers specifically to a **pseudogene**, which by definition lacks the function of the canonical gene. While its parent, 7SL RNA (RN7SL1), is functional and crucial in the SRP complex for co-translational protein targeting, RN7SL649P is not itself functionally active[1][3][5]. - Pseudogenes like RN7SL649P are sometimes referenced in genomic studies but are not directly involved in typical drug action, disease mechanisms, or biomarker applications[1][2][4]. - The target is **not misspelled or ambiguous**, but it is not a therapeutic target, nor does it have direct biochemical or clinical relevance as per the conventions requested. ### Summary of conventions - RN7SL649P is **not a therapeutic target**; it is a non-coding, non-functional pseudogene, best classified under "Other" as a molecular classification. No drugs, pathways, or disease roles apply. - There is nothing incorrect about the name or abbreviation, but functionally, it is not a conventional molecular target of interest for drug discovery or disease mechanisms[1][3][5].

Other names
RN7SL649P7SL RNA pseudogene 649

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 649, pseudogene (RN7SL649P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 649, pseudogene (RN7SL649P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call